1Timermans PB, Wong PC, Chiu AT, et al. Angiotensin Ⅱ receptors and angiotensin Ⅱ receptor antagonists [ J ]. Pharmacol Rev, 1993,45 : 205-251. 被引量：1
2Bauer JH, Reams GP. The angiotensin Ⅱ type 1 receptor antagonists. A new class of antihypertensive drugs[J]. Arch Intem Med, 1995, 155:1361-1368. 被引量：1
3Timmermans PB, Benfield P, Chiu AT, et al. Angiotensin Ⅱ receptors and functional correlates[ J]. Am J Hypertens, 1992,5 (Suppl) : 211 S-235S. 被引量：1
4Urate H, Strobel F, Ganten D. Widespread tissue distribution of human chymase[ J]. J Hypertens, 1994,12(Suppl) : S17-S22. 被引量：1
5Oparil S, Barr E, Elkins M, et al. Efficacy, tolerability, and effects on quality of lithe of losartan,alone or with hydro-chlorothiazide, in patients with essential hypertension[ J]. Clin Ther, 1996, 18:608-625. 被引量：1
6Holwerde NJ, Fogari R, Angeli P, et al. Valsartan, a new angiotensin Ⅱ antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril[ J]. J Hypertens, 1996,14:1147-1151. 被引量：1
7Hegner G, Faust G, Freytag F, et al. Valsartan, a new angiotensin Ⅱ antagonist for the treatment of essential hypertension: efficacy and salary compared to hydrocholorthiazide [ J]. Eur J Clin Pharmacol, 1997,52:173-177. 被引量：1
8Conlin PR, Spence JD, Williams B, et al. Angiotensin Ⅱ antagonists for hypertension: are there differences in efficacy [ J ] ? Am J Hypertens, 2000,13 : 418-426. 被引量：1
9Kassler-Taub K, Littlejohn T, Elliott W, et al. Comparative efficacy of two angiotensin Ⅱ receptor antagonists, irbesartan and losartan, in mild-to-moderate hypertension[J]. Am J Hypertens, 1998,1:445-453. 被引量：1
10Thuemann PA, Kenedi P, Sctunidt A, et al. Influence of the angiotensin Ⅱ antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension [ J ]. Circulation, 1998,98: 2037-2042. 被引量：1
